Sign In
Buy LFMD
$3.50
-0.140 (-3.85%)
At Close: Jul 31, 2026
Medifast Announces Second Quarter 2025 Financial Results
04:05pm, Monday, 04'th Aug 2025
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, today reported results for the second quarte
LifeMD to Participate in the Canaccord Genuity 45th Annual Growth Conference
08:00am, Monday, 04'th Aug 2025
NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced its participation in the Canaccord Genuity 45th Annual Gro
LifeMD Names COO and Promotes Two Executives
08:00am, Thursday, 31'st Jul 2025
NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual healthcare services, today announced the appointment of Shayna Webb Dray as its Chief Operating O
Hims & Hers vs. LifeMD: Which Telehealth Stock Has More Upside?
11:15am, Monday, 30'th Jun 2025
HIMS and LFMD are surging in the telehealth race, but which one has stronger earnings growth and expansion momentum? Let's see.
10 Under-the-Radar Healthcare Stocks With Incredible Growth Potential
09:10am, Saturday, 28'th Jun 2025
There's a strong case that healthcare is the most important sector in the stock market. These companies deliver innovative therapies and medical technologies that are often life-saving.
LifeMD: Inflection Into Profitability Should Drive Stock Upward
05:21am, Thursday, 26'th Jun 2025
LifeMD is a fast-growing, profitable telehealth company with strong partnerships, a robust tech stack and a valuable SaaS asset. The Novo Nordisk/Hims fallout is bullish, not bearish, for LifeMD. Novo
LifeMD: An Overlooked GLP-1 Beneficiary
03:02am, Wednesday, 25'th Jun 2025
LifeMD has evolved through multiple rebrandings, now offering 24/7 virtual primary and urgent care access to patients. The company operates RexMD, a men's telehealth platform, serving around 500,000 c
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
04:05pm, Monday, 23'rd Jun 2025
NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend
LifeMD to Participate in Two Investor Conferences During June
08:00am, Monday, 09'th Jun 2025
NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following inv
LifeMD: Growth, Growth, And More Growth
02:12pm, Wednesday, 04'th Jun 2025
LifeMD is experiencing a major growth inflection, with record Q1 revenue, first-ever GAAP profitability, and strong subscriber and margin gains. Multiple growth drivers - including GLP-1 programs, Med
LifeMD Collaborates with Novo Nordisk to Launch $299 Introductory Bundle for Self-Pay Patients Prescribed Wegovy®
08:05am, Thursday, 22'nd May 2025
Bundled Offer Includes Wegovy® at $199 and LifeMD's Virtual Weight Loss Program for a Total First-Month Cost of $299, $599 per Month Thereafter Bundled Offer Includes Wegovy® at $199 and LifeMD's Vi
LifeMD to Participate in Three Investor Conferences During May
04:05pm, Monday, 12'th May 2025
NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following inve
LifeMD, Inc. (LFMD) Q1 2025 Earnings Call Transcript
06:47pm, Tuesday, 06'th May 2025
LifeMD, Inc. (NASDAQ:LFMD ) Q1 2025 Earnings Conference Call May 6, 2025 4:30 PM ET Company Participants Justin Schreiber - Chairman and CEO Marc Benathen - Chief Financial Officer Conference Call Par
LifeMD, Inc. (LFMD) Q1 Earnings and Revenues Top Estimates
06:40pm, Tuesday, 06'th May 2025
LifeMD, Inc. (LFMD) came out with quarterly earnings of $0.01 per share, beating the Zacks Consensus Estimate of a loss of $0.04 per share. This compares to loss of $0.19 per share a year ago.
LifeMD Reports First Quarter 2025 Results and Raises Full-Year 2025 Guidance
04:05pm, Tuesday, 06'th May 2025
Total revenues increased 49% year-over-year to $65.7 million with telehealth revenue up 70% Adjusted EBITDA increased to $8.7 million from $0.1 million in the year-ago period Telehealth adjusted EBITD
